383 related articles for article (PubMed ID: 29852871)
1. Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer's Disease.
Zverova M; Kitzlerova E; Fisar Z; Jirak R; Hroudova J; Benakova H; Lelkova P; Martasek P; Raboch J
Curr Alzheimer Res; 2018; 15(10):938-950. PubMed ID: 29852871
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
4. Increased CSF cortisol in AD is a function of APOE genotype.
Peskind ER; Wilkinson CW; Petrie EC; Schellenberg GD; Raskind MA
Neurology; 2001 Apr; 56(8):1094-8. PubMed ID: 11320185
[TBL] [Abstract][Full Text] [Related]
5. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
[TBL] [Abstract][Full Text] [Related]
7. Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease.
Soares HD; Potter WZ; Pickering E; Kuhn M; Immermann FW; Shera DM; Ferm M; Dean RA; Simon AJ; Swenson F; Siuciak JA; Kaplow J; Thambisetty M; Zagouras P; Koroshetz WJ; Wan HI; Trojanowski JQ; Shaw LM;
Arch Neurol; 2012 Oct; 69(10):1310-7. PubMed ID: 22801723
[TBL] [Abstract][Full Text] [Related]
8. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
[TBL] [Abstract][Full Text] [Related]
10. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
Klages JD; Fisk JD; Rockwood K
Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
[TBL] [Abstract][Full Text] [Related]
12. The C677T variant in MTHFR modulates associations between blood-based and cerebrospinal fluid biomarkers of neurodegeneration.
Roussotte FF; Narr KL; Small GW; Thompson PM;
Neuroreport; 2016 Aug; 27(12):948-51. PubMed ID: 27380243
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
[TBL] [Abstract][Full Text] [Related]
14. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population.
Kim HC; Kim DK; Choi IJ; Kang KH; Yi SD; Park J; Park YN
Psychiatry Clin Neurosci; 2001 Apr; 55(2):115-20. PubMed ID: 11285089
[TBL] [Abstract][Full Text] [Related]
15. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
[TBL] [Abstract][Full Text] [Related]
16. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism.
Lehtovirta M; Soininen H; Helisalmi S; Mannermaa A; Helkala EL; Hartikainen P; Hänninen T; Ryynänen M; Riekkinen PJ
Neurology; 1996 Feb; 46(2):413-9. PubMed ID: 8614504
[TBL] [Abstract][Full Text] [Related]
17. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
[TBL] [Abstract][Full Text] [Related]
18. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype.
Ramassamy C; Averill D; Beffert U; Bastianetto S; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Davignon J; Quirion R; Poirier J
Free Radic Biol Med; 1999 Sep; 27(5-6):544-53. PubMed ID: 10490274
[TBL] [Abstract][Full Text] [Related]
19. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
